Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According to Sudarshan Sukhani of s2analytics.com, the correction in pharmaceutical stocks would be an opportunity.
Gaurav Bissa of LKP Securities advises buying Petronet LNG and Dish TV.
Basant Maheshwari, Founder of The Equity Desk And Author of The Thoughtful Investor is of the view that one may prefer pharma stocks.
Rajat Bose of rajatkbose.com recommends buying Wockhardt with a target of Rs 1659.
Manas Jaiswal of manasjaiswal.com recommends buying Firstsource Solutions with a target of Rs 47.50 and Indian Hotels with a target of Rs 120.
SP Tulsian of sptulsian.com is of the view that Lupin and Wockhardt look good.
Dipan Mehta, Member at BSE & NSE is of the view that one may prefer pharmaceutical stocks.
VK Sharma of HDFC Securities is of the view that one can buy Apollo Hospitals 1400 Call and Wockhardt 1650 Call.
Sudarshan Sukhani of s2analytics.com is upbeat on Glenmark Pharma, Wockhardt and Ajanta Pharma.
Dharmesh Kant of India Nivesh Securities is of the view that one may buy NCC with a target of Rs 90.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Wockhardt.
CNBC-TV18's research teams gets the list of those 10 stocks which are likely to remain in today's trading zone
Pankaj Jain of Sunteck Wealthmax advises buying S H Kelkar & Company with a target of Rs 225.
Chandan Taparia of Anand Rathi Securities is of the viwe that one can go long in Dabur, BPCL and Wockhardt.
Rakesh Bansal, Vice President at RK Global recommends buying Reliance Infra and Wockhardt.
Sudarshan Sukhani of s2analytics.com recommends buying Wockhardt.
SP Tulsian of sptulsian.com feels that Wockhardt may move to Rs 2000.
According to Manas Jaiswal of manasjaiswal.com, one may buy Wockhardt and Ceat.
SP Tulsian of sptulsian.com is positive on Wockhardt and feels that it may test Rs 2,200-2,400 in next six months.
CA Rudramurthy of Vachana Investments is of the view that one may sell Jubilant Foodworks with a target of Rs 1333.
Kunal Bothra of LKP Securities recommends buying Wockhardt and TVS Motor Company.
Hemen Kapadia of KR Choksey Securities is of the view that one may sell ITC with a target of Rs 351.
One may buy Nilkamal for a target of Rs 1090, with a stoploss of Rs 1,000, says CA Rudramurthy BV of Vachana Investments.
Sharmila Joshi of sharmilajoshi.com advises selling Federal Bank with a target of Rs 55.5.
Manish Hathiramani of Deen Dayal Investments recommends buying Bajaj Auto, Bosch, Wockhardt, Syndicate Bank and Strides Arcolab.